Piramal Enterprises Limited is the flagship company of the Piramal Group.
Piramal Enterprises Limited (PEL) is one of India's large diversified companies with presence in Pharma, Financial Services and Healthcare Information Management. The company generates ~46% of its revenues from international markets. Driven by both organic as well as inorganic strategy, PEL has steered dynamic business growth over the three decades of its existence.
Anticipating the potential of financial services in India, PEL built a platform with innovative financial solutions that cater to the needs of varied industry verticals.
It made its foray into the financial services sector with Piramal Capital & Housing Finance Limited (PCHFL), a housing finance company registered with the National Housing Bank (NHB) that is engaged in various financial services businesses. It provides end-to-end financing solutions in both wholesale and retail funding opportunities across sectors such as real estate and infrastructure, renewable energy, hospitality, logistics, industrials, auto components etc. Through its group companies, the platform has strategic partnerships with leading global pension funds such as Canadian Pension Plan Investment Board (CPPIB), APG and Ivanhoe Cambridge.
India Resurgence Fund (IndiaRF), an equal joint venture by Piramal Enterprises Limited and Bain Capital Credit, invests capital in the form of both debt and equity in India's distressed asset space.
When the Indian pharmaceutical industry was focused on international generics, PEL saw an opportunity to expand its pharma business and invested in the domestic formulation business.
Today, its Pharma division, has end-to-end manufacturing capabilities across 13 global facilities and a large global distribution network in over 100 countries. PEL sells a portfolio of niche differentiated pharma products and provides an entire pool of pharma services (including the areas of injectables, Highly Potent Active Pharmaceutical Ingredients (HPAPI) etc.).
When the world was talking about critical healthcare, PEL realised the power of data and information and invested in healthcare analytics.
PEL's Healthcare Insights & Analytics business division is the premier provider of healthcare analytics, data & insight products and services to the world's leading pharma, biotech and medical technology companies and enables them to take informed business decisions.
PEL's corporate ethos, a reflection of its core values – Knowledge, Action, Care and Impact, has enabled the company to develop and consolidate a coveted international business network of strong partnerships with global market leaders, committed to creating long-term value to all stakeholders.
Operational excellence fuelled by continued innovation
Delivering sustained long-term value to all stakeholders
Fostering an environment of entrepreneurship